ATE350029T1 - Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain - Google Patents
Pharmazeutische zusammensetzung enthaltend gamma- butyrobetainInfo
- Publication number
- ATE350029T1 ATE350029T1 AT02702955T AT02702955T ATE350029T1 AT E350029 T1 ATE350029 T1 AT E350029T1 AT 02702955 T AT02702955 T AT 02702955T AT 02702955 T AT02702955 T AT 02702955T AT E350029 T1 ATE350029 T1 AT E350029T1
- Authority
- AT
- Austria
- Prior art keywords
- butyrobetain
- pharmaceutical composition
- composition containing
- containing gamma
- gamma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-01-134A LV12979B (en) | 2001-09-07 | 2001-09-07 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350029T1 true ATE350029T1 (de) | 2007-01-15 |
Family
ID=19735292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02702955T ATE350029T1 (de) | 2001-09-07 | 2002-03-04 | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20040242590A1 (de) |
| EP (1) | EP1429753B1 (de) |
| JP (1) | JP4382480B2 (de) |
| KR (1) | KR100841035B1 (de) |
| CN (1) | CN1275595C (de) |
| AR (1) | AR036423A1 (de) |
| AT (1) | ATE350029T1 (de) |
| AU (1) | AU2002236340B2 (de) |
| BG (1) | BG108673A (de) |
| CA (1) | CA2459719C (de) |
| CU (1) | CU23347B6 (de) |
| DE (1) | DE60217369T2 (de) |
| DK (1) | DK1429753T3 (de) |
| EA (1) | EA006675B1 (de) |
| ES (1) | ES2280505T3 (de) |
| HK (1) | HK1068003A1 (de) |
| HR (1) | HRPK20040328B3 (de) |
| IL (2) | IL160734A0 (de) |
| JO (1) | JO2507B1 (de) |
| LV (1) | LV12979B (de) |
| MA (1) | MA27683A1 (de) |
| MX (1) | MXPA04002050A (de) |
| MY (1) | MY134074A (de) |
| NZ (1) | NZ532178A (de) |
| PL (1) | PL368758A1 (de) |
| PT (1) | PT1429753E (de) |
| SI (1) | SI1429753T1 (de) |
| TW (1) | TWI224506B (de) |
| WO (1) | WO2003022262A1 (de) |
| ZA (1) | ZA200402702B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10325813B4 (de) * | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
| LV13450B (en) * | 2004-08-24 | 2006-11-20 | Grindeks As | Novel medicinal use of meldonium and pharmaceutical compositions thereof |
| WO2007016361A2 (en) | 2005-07-29 | 2007-02-08 | Concert Pharmaceuticals Inc. | Novel pharmaceutical compounds |
| WO2009095445A1 (en) * | 2008-01-29 | 2009-08-06 | Grindeks | New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate |
| CN101781302B (zh) * | 2009-05-31 | 2013-07-10 | 段波 | 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用 |
| RU2622757C1 (ru) * | 2016-06-02 | 2017-06-19 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | Способ лечения эректильной дисфункции |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1198434B (it) * | 1981-01-06 | 1988-12-21 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina |
| LV11727B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
| LV11728B (en) | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
-
2001
- 2001-09-07 LV LVP-01-134A patent/LV12979B/en unknown
-
2002
- 2002-03-04 ES ES02702955T patent/ES2280505T3/es not_active Expired - Lifetime
- 2002-03-04 MX MXPA04002050A patent/MXPA04002050A/es active IP Right Grant
- 2002-03-04 SI SI200230507T patent/SI1429753T1/sl unknown
- 2002-03-04 JP JP2003526391A patent/JP4382480B2/ja not_active Expired - Fee Related
- 2002-03-04 KR KR1020047003366A patent/KR100841035B1/ko not_active IP Right Cessation
- 2002-03-04 EP EP02702955A patent/EP1429753B1/de not_active Expired - Lifetime
- 2002-03-04 DE DE60217369T patent/DE60217369T2/de not_active Expired - Lifetime
- 2002-03-04 IL IL16073402A patent/IL160734A0/xx unknown
- 2002-03-04 PT PT02702955T patent/PT1429753E/pt unknown
- 2002-03-04 DK DK02702955T patent/DK1429753T3/da active
- 2002-03-04 AT AT02702955T patent/ATE350029T1/de not_active IP Right Cessation
- 2002-03-04 WO PCT/LV2002/000004 patent/WO2003022262A1/en active IP Right Grant
- 2002-03-04 CA CA2459719A patent/CA2459719C/en not_active Expired - Fee Related
- 2002-03-04 CN CNB028175077A patent/CN1275595C/zh not_active Expired - Fee Related
- 2002-03-04 EA EA200400386A patent/EA006675B1/ru not_active IP Right Cessation
- 2002-03-04 PL PL02368758A patent/PL368758A1/xx unknown
- 2002-03-04 AU AU2002236340A patent/AU2002236340B2/en not_active Ceased
- 2002-03-04 US US10/488,840 patent/US20040242590A1/en not_active Abandoned
- 2002-03-04 NZ NZ532178A patent/NZ532178A/en unknown
- 2002-08-29 MY MYPI20023224A patent/MY134074A/en unknown
- 2002-09-04 AR ARP020103331A patent/AR036423A1/es unknown
- 2002-09-05 TW TW091120239A patent/TWI224506B/zh not_active IP Right Cessation
- 2002-09-05 JO JO200291A patent/JO2507B1/en active
-
2004
- 2004-03-04 IL IL160734A patent/IL160734A/en not_active IP Right Cessation
- 2004-03-04 CU CU20040040A patent/CU23347B6/es unknown
- 2004-04-05 MA MA27608A patent/MA27683A1/fr unknown
- 2004-04-06 ZA ZA200402702A patent/ZA200402702B/en unknown
- 2004-04-07 BG BG108673A patent/BG108673A/xx unknown
- 2004-04-07 HR HR20040328A patent/HRPK20040328B3/xx not_active IP Right Cessation
-
2005
- 2005-01-11 HK HK05100218A patent/HK1068003A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355271T1 (de) | Pharmazeutische zusammensetzung | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| DE60213592D1 (de) | Flüssige pharmazeutische zusammensetzung | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| FI20011478A (fi) | Farmaseuttinen koostumus | |
| NO20033384D0 (no) | Farmasöytisk formulering | |
| NO20033556L (no) | Farmasöytiske formuleringer | |
| ATE331529T1 (de) | Antigen enthaltende pharmazeutische zusammensetzung | |
| ATE320807T1 (de) | Pharmazeutische zusammensetzungen enthaltend tegaserod | |
| NO20035627D0 (no) | Farmasöytisk formulering | |
| ATE477814T1 (de) | Stabile faktor-viii enthaltende pharmazeutische zusammensetzung | |
| DE60211183D1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
| FI20022128A0 (fi) | Farmaseuttinen koostumus | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
| DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
| ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
| NO20033073L (no) | Farmasöytisk sammensetning inneholdende citalopram | |
| DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
| NO20041236L (no) | Farmasoytisk formulering | |
| FI5468U1 (fi) | Farmaseuttinen koostumus | |
| SE0100847D0 (sv) | Novel pharmaceutical composition | |
| SE0101326D0 (sv) | Pharmaceutical formulation | |
| SE0102069D0 (sv) | Pharmaceutical formulation | |
| SE0102572D0 (sv) | Pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1429753 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |